Nephros

GenArraytion Inc. is a veteran-owned small business based in Rockville, Maryland, specializing in medical diagnostics and molecular genotyping technologies. The company provides a range of products and services focused on the detection and analysis of tick- and mosquito-borne diseases, as well as testing for food and water safety, biodefense, and environmental monitoring. Their innovative offerings include MultiFLEX Bioassays and Sniper Sequencing genotyping services, which facilitate rapid and precise infectious disease assays. GenArraytion has developed advanced technologies such as real-time multiplexed PCR assays, bead-based assays, and custom microarrays that enable the simultaneous detection of multiple pathogens and the antimicrobial characterization of clinically relevant strains. The company is registered in the CCR database and holds ORCA certification, underscoring its commitment to quality and regulatory compliance in its operations.

Biocon Limited, established in 1978 and headquartered in Bengaluru, India, is a fully integrated biopharmaceutical company. It specializes in the development, manufacturing, and commercialization of a wide range of biopharmaceuticals, including biosimilars, novel biologics, and complex small molecule APIs. Biocon's portfolio spans recombinant human insulin, insulin analogs, monoclonal antibodies, and therapeutic proteins, targeting areas like diabetes, oncology, and immunology. The company operates through four segments: Biosimilars, Generics, Novel Biologics, and Research Services. It also offers contract research and manufacturing services to the pharmaceutical industry through its subsidiary, Syngene. Biocon's mission is to expand patient access to affordable, high-quality biopharmaceuticals, driven by a commitment to innovation and humanitarian responsibility.